| Risk factors for herpes zoster infection: a meta-analysis F Marra, K Parhar, B Huang, NK Vadlamudi Open forum infectious diseases 7 (1), ofaa005, 2020 | 194 | 2020 |
| Impact of the 13-valent pneumococcal conjugate vaccine among adults: a systematic review and meta-analysis NK Vadlamudi, A Chen, F Marra Clinical Infectious Diseases 69 (1), 34-49, 2019 | 57 | 2019 |
| Cadth’s $50,000 cost-effectiveness threshold: fact or fiction? EA Griffiths, NK Vadlamudi Value in Health 19 (7), A488-A489, 2016 | 47 | 2016 |
| The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis F Marra, A Zhang, E Gillman, K Bessai, K Parhar, NK Vadlamudi International Journal of Infectious Diseases 99, 204-213, 2020 | 37 | 2020 |
| Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and … NK Vadlamudi, K Parhar, KLA Malana, A Kang, F Marra Vaccine 37 (8), 1021-1029, 2019 | 33 | 2019 |
| The role of noncomparative evidence in health technology assessment decisions EA Griffiths, R Macaulay, NK Vadlamudi, J Uddin, ER Samuels Value in Health 20 (10), 1245-1251, 2017 | 30 | 2017 |
| Efficacy and safety of the pneumococcal conjugate-13 valent vaccine in adults F Marra, NK Vadlamudi Aging and disease 10 (2), 404, 2019 | 28 | 2019 |
| Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study NK Vadlamudi, DM Patrick, L Hoang, M Sadarangani, F Marra PloS one 15 (9), e0239848, 2020 | 14 | 2020 |
| Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada NK Vadlamudi, A Saatchi, DM Patrick, C Rose, M Sadatsafavi, F Marra Journal of Antimicrobial Chemotherapy 76 (9), 2419-2427, 2021 | 10 | 2021 |
| The impact of mask mandates on face mask use during the COVID-19 pandemic: longitudinal survey study M Binka, PA Adu, D Jeong, NK Vadlamudi, HAV García, B Mahmood, ... JMIR Public Health and Surveillance 9 (1), e42616, 2023 | 9 | 2023 |
| Immunogenicity and safety of the COVID-19 vaccines compared with control in healthy adults: A qualitative and systematic review O Lau, NK Vadlamudi Value in Health 25 (5), 717-730, 2022 | 9 | 2022 |
| Pediatric RSV-associated hospitalizations before and during the COVID-19 pandemic M Bourdeau, NK Vadlamudi, N Bastien, J Embree, SA Halperin, T Jadavji, ... JAMA Network Open 6 (10), e2336863-e2336863, 2023 | 8 | 2023 |
| The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review NK Vadlamudi, CA Basham, JC Johnston, F Ahmad Khan, ... PLOS Global Public Health 3 (7), e0002163, 2023 | 6 | 2023 |
| Strategies to Prevent Early and Late-Onset Group B Streptococcal Infection via Interventions in Pregnancy M Delara, NK Vadlamudi, M Sadarangani Pathogens 12 (2), 229, 2023 | 5 | 2023 |
| Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018 KAT Khaled Alsager 1, Nirma Khatri Vadlamudi 2 3, Taj Jadavji 1, Julie A ... Human Vaccines & Immunotherapeutics 18 (5), 2088215, 2022 | 5 | 2022 |
| A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada NK Vadlamudi, DM Patrick, C Rose, M Sadatsafavi, L Hoang, F Marra Vaccine 40 (7), 1047-1053, 2022 | 3 | 2022 |
| Not ready for the real world? The role of non-RCT evidence in health technology assessment EA Griffiths, NK Vadlamudi Value in Health 19 (3), A286, 2016 | 3 | 2016 |
| Using Social Media to Help Understand Patient-Reported Health Outcomes of Post–COVID-19 Condition: Natural Language Processing Approach E Dolatabadi, D Moyano, M Bales, S Spasojevic, R Bhambhoria, J Bhatti, ... Journal of Medical Internet Research 25, e45767, 2023 | 2 | 2023 |
| CO105 The Association of Sars-Cov-2 Infection and Tuberculosis Disease with Unfavorable Treatment Outcomes: A Systematic Review N Vadlamudi, CA Basham, JC Johnston, FA Khan, GB Migliori, R Centis, ... Value in Health 26 (6), S34, 2023 | 2 | 2023 |
| Using Social Media to Help Understand Long COVID Patient Reported Health Outcomes: A Natural Language Processing Approach E Dolatabadi, D Moyano, M Bales, S Spasojevic, R Bhambhoria, J Bhatti, ... medRxiv, 2022.12. 14.22283419, 2022 | 1 | 2022 |
Linda M. N. Hoang在 bccdc.ca 的电子邮件经过验证
